Nanomaterials for the treatment and diagnosis of Alzheimer's disease: an overview
Alzheimer's disease (AD) is a chronic neurodegenerative disorder associated with
dementia. To overcome the limitations of diagnosis and treatment nanotechnology research …
dementia. To overcome the limitations of diagnosis and treatment nanotechnology research …
Chemical sensing platforms for detecting trace-level Alzheimer's core biomarkers
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and affects more
than 10% of the population aged over 65 worldwide. Despite considerable global efforts, AD …
than 10% of the population aged over 65 worldwide. Despite considerable global efforts, AD …
[HTML][HTML] Single-atom nanozymes linked immunosorbent assay for sensitive detection of Aβ 1-40: a biomarker of Alzheimer's disease
Single-atom nanozymes (SANs) possess unique features of maximum atomic utilization and
present highly assembled enzyme-like structure and remarkable enzyme-like activity. By …
present highly assembled enzyme-like structure and remarkable enzyme-like activity. By …
Nanomaterials towards biosensing of Alzheimer's disease biomarkers
P Carneiro, S Morais, MC Pereira - Nanomaterials, 2019 - mdpi.com
Alzheimer's disease (AD) is an incurable and highly debilitating condition characterized by
the progressive degeneration and/or death of nerve cells, which leads to manifestation of …
the progressive degeneration and/or death of nerve cells, which leads to manifestation of …
Nanoelectrokinetic-assisted lateral flow assay for COVID-19 antibody test
A lateral flow assay (LFA) platform is a powerful tool for point-of-care testing (POCT),
especially for self-testing. Although the LFA platform provides a simple and disposable tool …
especially for self-testing. Although the LFA platform provides a simple and disposable tool …
Biosensors on the road to early diagnostic and surveillance of Alzheimer's disease
P Carneiro, S Morais, M do Carmo Pereira - Talanta, 2020 - Elsevier
Alzheimer's disease is a debilitating and largely untreatable condition with subtle onset and
slow progression over an extensive period of time, which culminate in increasing levels of …
slow progression over an extensive period of time, which culminate in increasing levels of …
Nanomaterial-based Optical and Electrochemical Biosensors for Amyloid beta and Tau: Potential for early diagnosis of Alzheimer's Disease
Introduction Alzheimer's disease (AD), a heterogeneous pathological process representing
the most common causes of dementia worldwide, has required early and accurate …
the most common causes of dementia worldwide, has required early and accurate …
Low-powered pH-stable nano-electrokinetically enhanced lateral flow assay for COVID-19 antigen test
Lateral flow assay (LFA) is a popular diagnostic system used in point-of-care testing (POCT)
due to its low cost and portability. However, LFA has limited sensitivity and detection limits …
due to its low cost and portability. However, LFA has limited sensitivity and detection limits …
Gold nanoparticles assisted sensitivity improvement of interdigitated microelectrodes biosensor for amyloid-β detection in plasma sample
Amyloid-β (Aβ) is a peptide that is produced in the brain and carried across the blood brain
barrier to the blood. It is an important biomarker for the blood-based diagnosis of early stage …
barrier to the blood. It is an important biomarker for the blood-based diagnosis of early stage …
Advances in the development paradigm of biosample‐based biosensors for early ultrasensitive detection of alzheimer's disease
This review highlights current developments, challenges, and future directions for the use of
invasive and noninvasive biosample-based small biosensors for early diagnosis of …
invasive and noninvasive biosample-based small biosensors for early diagnosis of …